News

Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...
Biotech veteran and Stanford physician-scientist brings 30 years of translational research and regulatory experience to ...
Marty Makary, commissioner of the FDA, is naming George Tidmarsh director of the Center for Drug Evaluation and Research.
George Francis Tidmarsh, MD, PhD, founding co-director of Stanford’s Master of Translational Research and Applied Medicine ...
George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...
By Stephanie Brown HealthDay ReporterWEDNESDAY, July 23, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has appointed George Francis Tidmarsh, M.D., Ph.D., as director of the Center ...
The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.
The FDA appointed George F. Tidmarsh, MD, PhD, the director of the Center for Drug Evaluation and Research, the agency ...
“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development — ...
FDA Commissioner Marty Makary, M.D., has made his pick for the next director of the FDA’s Center for Drug Evaluation and ...
George Tidmarsh appointed to lead FDA drug review division amid staffing cuts and scrutiny over accelerated approvals and ...
Tidmarsh has most recently been serving as adjunct professor of paediatrics and neonatology at Stanford University ...